1. C-peptide exhibits a late induction effect on matrix metallopeptidase-9 in high glucose-stimulated rat mesangial cells
   Junxia Wang et al, 2016, Experimental and Therapeutic Medicine CrossRef
2. MicroRNAs as Regulators of Immune and Inflammatory Responses: Potential Therapeutic Targets in Diabetic Nephropathy
   Hong Zhou et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
3. Hsa_circ_0008360 promotes high glucose-induced damage in HK-2 cells via miR-346/WNT2B axis
   L. Zhang et al, 2024, Journal of Endocrinological Investigation CrossRef
4. WGCNA Analysis Identifies Polycystic Ovary Syndrome-Associated Circular RNAs That Interact with RNA-Binding Proteins and Sponge miRNAs
   Mengxiong Li et al, 2021, International Journal of General Medicine CrossRef
5. MicroRNAs: Key modulators of inflammation-associated diseases
   Bilash Chatterjee et al, 2024, Seminars in Cell & Developmental Biology CrossRef
6. Immune responses in diabetic nephropathy: Pathogenic mechanisms and therapeutic target
   Jiahao Chen et al, 2022, Frontiers in Immunology CrossRef
7. Alpinia oxyphylla Miq. extract changes miRNA expression profiles in db-/db- mouse kidney
   Guankui Du et al, 2017, Biological Research CrossRef
8. miR-346 regulates the development of ARDS by regulating the function of pulmonary microvascular endothelial cells
   Jing Jiang et al, 2023, Non-coding RNA Research CrossRef
9. Identification of candidate microRNA biomarkers in diabetic nephropathy: a meta-analysis of profiling studies
   Alieh Gholaminejad et al, 2018, Journal of Nephrology CrossRef
10. Safety and Dosing Study of a Cholecystokinin Receptor Antagonist in Non‐alcoholic Steatohepatitis
    Atoosa Rabiee et al, 2022, Clinical Pharmacology & Therapeutics CrossRef
11. Comprehensive analysis of differentially expressed microRNAs and mRNAs in dorsal root ganglia from streptozotocin-induced diabetic rats
    Guojun Guo et al, 2018, PLOS ONE CrossRef
12. Long non-coding RNA DLX6-AS1 is the key mediator of glomerular podocyte injury and albuminuria in diabetic nephropathy by targeting the miR-346/GSK-3β signaling pathway
    Jia Guo et al, 2023, Cell Death & Disease CrossRef
13. Regulatory Mechanisms of the Molecular Pathways in Fibrosis Induced by MicroRNAs
    Cui Yang et al, 2016, Chinese Medical Journal CrossRef
14. Nephrin loss is reduced by grape seed proanthocyanidins in the experimental diabetic nephropathy rat model
    Xianhua Li et al, 2017, Molecular Medicine Reports CrossRef
15. CircGAB1 Facilitates Podocyte Injury Through Sponging miR-346 and Activating MAPK6 in Diabetic Nephropathy
    Pingyue Ma et al, 2024, Applied Biochemistry and Biotechnology CrossRef
16. Alisol A inhibits the circ_0001831/miR‐346/LIN28B pathway to ameliorate high glucose‐induced injury of human renal mesangial cells
    Chunjing Yue et al, 2024, Nephrology CrossRef
17. Pathogenesis and Development of Patellar Tendon Fibrosis in a Rabbit Overuse Model
    Haitao Liu et al, 2020, The American Journal of Sports Medicine CrossRef
18. The effects of expression of different microRNAs on insulin secretion and diabetic nephropathy progression
    Alireza Mafi et al, 2019, Journal of Cellular Physiology CrossRef
19. Cholecystokinin Receptor Antagonist Improves Efficacy of Chemotherapy in Murine Models of Pancreatic Cancer by Altering the Tumor Microenvironment
    Zoe X. Malchiodi et al, 2021, Cancers CrossRef
20. Non-genetic mechanisms of diabetic nephropathy
    Qiuxia Han et al, 2017, Frontiers of Medicine CrossRef